Fondazione “Leonardo Giambrone” per la Guarigione dalla Thalassemia onlus, a not-for-profit body founded in 1992 to promote the development of definitive thalassaemia therapies, divulged a press release to promote the development of gene therapy in thalassaemic...
The ninety-seventh edition of the Giro d'Italia was officially launched on May 9th in Belfast. The startlist of the cycling event includes 22 teams for a total of 219 runners, cycling for about 3465 km in 21 stages. The first Italian stages started from Giovinazzo the...
The Regulation on Clinical trials on Medicinal Products for human use (Regulation (EU) No 536/2014 of the European Parliament and of The Council of 16 April 2014) has been published in the Official Journal of the European Union. This Regulation will replace the...
Representatives from DG Health and Consumers (European Commission), European Medicines Agency (EMA) and the American agency Food and Drug Administration (FDA) discussed a number of key initiatives at a bilateral meeting which took place in London from 31 March to 1...
The first InNerMeD-I-Network Open Conference was held in Frankfurt on March 7th – 9th, 2014 (attached the scientific programme of the workshop). The meeting was aimed to enable the exchange of information among clinicians, basic scientists, experts specialised on...
The first International Master on Regulatory Science has been presented on the 1st of March 2014 in Samsun (Turkey), in the framework of the workshop on internationalisation of Higher Education. The Master, with duration of one year, is promoted by Fondazione Gianni...
The new edition of the two-year Master in Regulatory Science "G.Benzi", organised by the University of Pavia, has been launched. The Master, involving as teachers highly qualified experts and professors from different universities, aims to train new experienced...
For the second time since the entry into force of the Paediatric Regulation (Reg. EC 1901/2006), the European Medicines Agency (EMA) has granted a positive opinion for a paediatric-use marketing authorisation (PUMA). The object of the opinion is Hemangiol, a drug for...
The first calls under the new EU Framework Programme for Research and Innovation "Horizon 2020" have been published. For the 2014-2015 period, 15 billion has been allocated. 7,8 billion assigned for the year 2014 are focused on the three pillars of Horizon 2020...
The website dedicated to the project InNerMeD-I-Network is now available online. The website, accessible to the public thanks to an easy-to-use interface, is aimed to disseminate all the project activities and its results. Here, you can also download the electronic...
Recent posts in News